Pacific Biosciences Of California (PACB) Accounts Payables (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Accounts Payables of $13.6 million for Q1 2026, down 3.05% year-over-year from $14.0 million in Q1 2025, and down 34.48% quarter-over-quarter from $20.8 million in Q4 2025.
Pacific Biosciences Of California (PACB) Accounts Payables (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Accounts Payables history runs 17 years deep, the most recent figure standing at $13.6 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 3.05% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (down 3.05% YoY), while the FY2025 annual figure was $20.8 million, up 25.2% from the prior year.
- Accounts Payables for Q1 2026 stood at $13.6 million, down from $20.8 million in the prior quarter.
- The five-year high for Accounts Payables was $21.0 million in Q1 2024, with the low at $12.0 million in Q4 2022.
- The 5-year median for Accounts Payables is $16.1 million (2023), against an average of $15.7 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 407.26% in 2022, then sank 33.18% in 2025.
- Pacific Biosciences Of California's Accounts Payables stood at $12.0 million in 2022, then gained by 25.22% to $15.1 million in 2023, then increased by 10.14% to $16.6 million in 2024, then climbed by 25.2% to $20.8 million in 2025, then tumbled by 34.48% to $13.6 million in 2026.
- Business Quant data shows PACB's Accounts Payables at $13.6 million in Q1 2026, $20.8 million in Q4 2025, and $16.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Pacific Biosciences Of California | 398.57 Mn | 161.70 Mn | 12.64 Mn | 19.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.22 Mn |
| Mar 31, 2026 | 13.61 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 16.36 Mn |
| Jun 30, 2025 | 15.06 Mn |
| Mar 31, 2025 | 14.04 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 17.49 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 15.06 Mn |
| Sep 30, 2023 | 16.11 Mn |
| Jun 30, 2023 | 16.51 Mn |
| Mar 31, 2023 | 17.39 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 12.85 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 17.61 Mn |
| Dec 31, 2021 | 11.00 Mn |
| Jun 30, 2021 | 4.76 Mn |